Treatment of severe pulmonary hypertension secondary to chronic lung disease: A multicentre study.

V. Prudencio Ribera (Madrid, Spain), A. Aurtenetxe Pérez (Bilbao, Spain), M. Coronel (Corrientes, Argentina), V. Pérez González (Madrid, Spain), F. Mazo Etxaniz (Bilbao, Spain), M. Velázquez Martín (Madrid, Spain), C. Quezada Loaiza (Madrid, Spain), P. Escribano Subías (Madrid, Spain)

Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Session: Pulmonary hypertension in lung diseases
Session type: E-poster session
Number: 292
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Prudencio Ribera (Madrid, Spain), A. Aurtenetxe Pérez (Bilbao, Spain), M. Coronel (Corrientes, Argentina), V. Pérez González (Madrid, Spain), F. Mazo Etxaniz (Bilbao, Spain), M. Velázquez Martín (Madrid, Spain), C. Quezada Loaiza (Madrid, Spain), P. Escribano Subías (Madrid, Spain). Treatment of severe pulmonary hypertension secondary to chronic lung disease: A multicentre study.. 292

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Phenotype of patients with severe pulmonary hypertension secondary to chronic obstructive pulmonary disease: A multicentre study.
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Year: 2013

The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Role and distribution of infectious agents in exacerbations of moderate, severe and very severe forms of chronic obstructive lung disease: a prospective trial
Source: Eur Respir J 2006; 28: Suppl. 50, 735s
Year: 2006

Prevalence of pulmonary arterial hypertension in idiopathic pulmonary fibrosis: a multicenter study
Source: Eur Respir J 2007; 30: Suppl. 51, 119s
Year: 2007

Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial
Source: ERJ Open Res, 5 (3) 00110-2019; 10.1183/23120541.00110-2019
Year: 2019



Self-efficacy. Does it change as a result of pulmonary rehabilitation? A pilot study
Source: Annual Congress 2006 - Effective strategies for chronic respiratory patient management
Year: 2006


Comparison of two physiotherapy treatments in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021


Severe pulmonary hypertension in lung disease: phenotypes and response to treatment
Source: Eur Respir J 2015; 46: 1378-1389
Year: 2015



Progression to a severe form of COVID-19 among patients with chronic respiratory diseases: a French multicentric study.
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021


The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients.
Source: Eur Respir J 2002; 20: 1617
Year: 2002


Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Association between chronic obstructive pulmonary disease and endometriosis: a population-based cohort study
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020

The prospective impact of chronic obstructive pulmonary disease on short-term prognosis of patients with chronic heart failure
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020

Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


Prospective study of infectious bacterial etiology of acute exacerbation of chronic obstructive pulmonary disease in India
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


Hemodynamics and response to therapy of pulmonary hypertension in patients with interstitial lung disease: Preliminary results of the "HYPID" prospective study
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012

Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study
Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019
Year: 2019